The USC Jorge H. Mestman Endocrine and Women's Health Symposium 2026

Welcome to the USC Jorge H. Mestman Symposium on Endocrine and Women's Health! This program is proudly presented in honor of Jorge H. Mestman, MD-a passionate physician, inspiring teacher and beloved mentor for over 40 years and counting. His ground-breaking work in endocrine conditions during pregnancy continues to shape how patients are cared for today. Dr. Mestman's unwavering commitment to clinical excellence and collaboration is the heartbeat of this symposium.

A Dynamic, Practical Program: Our symposium is designed to keep you at the forefront of endocrine medicine-covering both the standards of care and emerging trends. You'll hear from leaders in the field through evidence-based presentations, expert clinical insights, and lively panel discussions fueled by your questions. The exciting agenda focuses on optimizing care for patients with MASLD, diabetes, bariatric surgery, PCOS and hypothyroidism prior to pregnancy.

New This Year: Spotlight on Menopause! We are excited to broaden our focus on women's health with a brand-new menopause series. This dedicated track explores everything from the fundamentals of menopause care to cutting-edge research on how (peri) menopause impacts brain and bone health. Join us in person to add your energy for insightful, interactive Q&A sessions and a panel discussion with the experts.

Why Attend? Whether managing complex cases in pregnancy or seeking to broaden your knowledge of endocrine conditions affecting women, this symposium offers the tools and knowledge to inform your decisions in today's evolving clinical landscape.

1. Identify and evaluate metabolic dysfunction-associated steatotic liver disease (MASLD) in women of reproductive age, and describe pregnancy-related risks and management strategies.
2. Optimize diabetes management in women of reproductive age who are planning pregnancy, with a focus on preconception glycemic control and medication safety.
3. Prescribe and monitor appropriate vitamin and micronutrient supplementation for patients with a history of bariatric or gastric surgery during preconception and pregnancy.
4. Know fertility preservation and treatment options for patients with polycystic ovary syndrome (PCOS).
5. Implement evidence-based management of hypothyroidism across the reproductive lifespan, from preconception through menopause.
6. Counsel patients on the impact of perimenopause and menopause on metabolic, cognitive, and bone health, and discuss both hormonal and non-hormonal treatment options.

The Keck School of Medicine of the University of Southern California designates this Live Activity activity for a maximum of 6.25 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Cancellation Policy

Cancellations must be received by the USC Office of CME by email only by Feb. 24, 2026 by 12:00 pm PST for a refund. A $50 cancellation fee will be applied. In the event of course cancellation by conference organizers, all registration fees will be fully refunded. USC will not refund any travel costs incurred.


Accessibility Statement
 
Keck School of Medicine Healthcare System is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008. If you have needs that require special accommodations, including dietary concerns, please contact the USC Office of CME at [email protected].

The Keck School of Medicine Healthcare System School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Keck School of Medicine Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Braden Barnett, MD
Clinical Assistant Professor
Keck Medical Center of USC
Los Angeles, CA

Faculty

Speakers Bureau-Dexcom (Relationship has ended)

Alyssa L Dominguez, MD
Keck School of Medicine of USC
Los Angeles, CA

Faculty

Advisor-SynchNeuro

Nicole Gomez, MD, Physician
Doctoe
USC OB GYN
Los angeles , CA

Faculty

Juliana M Kling , MD
Professor of Medicine
Mayo Clinic
Cave Creek , AZ

Faculty

Honoraria-Inflection (Relationship has ended)|Honoraria-AiCME (Relationship has ended)|Consulting Fee-Naviday (Relationship has ended)|Consulting Fee-Y Story (Relationship has ended)|Honoraria-Bayer (Relationship has ended)|Honoraria-EPG health (Relationship has ended)|Honoraria-Vindico Medical educaiton (Relationship has ended)|Honoraria-Elsevier (Relationship has ended)

Katherine E McDaniel, MD
Dr.
HRC Fertility/University of Southern California
Los Angeles, CA

Faculty

Nothing to disclose

Caroline T Nguyen, MD
KSOM-Keck School of Medicine
Los Angeles, CA

Faculty

Nothing to disclose

Komal Patil-Sisodia, MD
EvergreenHealth
Redmond, WA

Faculty

Nothing to disclose

Donna Shoupe, MD
Professor
LACUSC
LA, CA, CA

Faculty

Speakers Bureau-Astellas Pharma (Relationship has ended)

Norah Terrault, MD, MPH
Professor of Medicine
USC
Los Angeles, CA

Faculty

Saturday, February 28, 2026